Crossover Evaluation of Effect of Atorvastatin on PK of Irinotecan in CRC Patients Receiving FOLFIRI
Status:
Withdrawn
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of atorvastatin on the pharmacokinetic
profile of irinotecan and SN-38. To further evaluate the safety of atorvastatin in
combination with FOLFIRI. To further evaluate the safety and of irinotecan in combination
with atorvastatin.